DOUGLAS CHARLES MACLELLAN Insider Trading $RXPC RADIENT PHARMACEUTICALS Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS CHARLES MACLELLAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS CHARLES MACLELLAN. DOUGLAS CHARLES MACLELLAN is Chief Executive Officer in RADIENT PHARMACEUTICALS Corp ($RXPC) and Director in RADIENT PHARMACEUTICALS Corp ($RXPC) and Director in AXM PHARMA INC ($AXMA) and Director in OCEAN SMART, INC. ($EDWT) and Director in ChinaNet Online Holdings, Inc. ($CNET) and Director in Star Mountain Resources, Inc. ($SMRS) and Director in Oroplata Resources, Inc. ($ORRP).
DOUGLAS CHARLES MACLELLAN in RADIENT PHARMACEUTICALS Corp
Trading Symbol: RXPCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS CHARLES MACLELLAN: Chief Executive Officer, Director
Holdings: 1,100 shares
Latest Transaction: Oct 19 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DOUGLAS CHARLES MACLELLAN in RADIENT PHARMACEUTICALS Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ORRP, EDWT, AXMA, RXPC, SMRS, CNET
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 200,000 | 150,000 | 446,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 90,000 | 67,500 | 246,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 120,000 | 90,000 | 156,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 36,000 | 27,000 | 36,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | J | 0.00 | 200,000 | 0 | 1,100 | 201.1 K to 1.1 K (-99.45 %) |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Chief Executive Off ... | Grant | A | 0.72 | 200,000 | 144,000 | 201,100 | 1.1 K to 201.1 K (+18,181.82 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | P | 2.68 | 1,000 | 2,684 | 1,100 | 100 to 1.1 K (+1,000.00 %) |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 3.45 | 200,000 | 690,000 | 485,000 | |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | M | 2.40 | 13,000 | 31,200 | 285,000 | |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.86 | 300 | 1,158 | 0 | 300 to 0 (-100.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.80 | 1,700 | 6,460 | 300 | 2 K to 300 (-85.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.79 | 125 | 474 | 2,000 | 2.1 K to 2 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.78 | 875 | 3,308 | 2,125 | 3 K to 2.1 K (-29.17 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.76 | 200 | 752 | 3,000 | 3.2 K to 3 K (-6.25 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.75 | 500 | 1,875 | 3,200 | 3.7 K to 3.2 K (-13.51 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.74 | 300 | 1,122 | 3,700 | 4 K to 3.7 K (-7.50 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.71 | 300 | 1,113 | 4,000 | 4.3 K to 4 K (-6.98 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.70 | 2,200 | 8,140 | 4,300 | 6.5 K to 4.3 K (-33.85 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.66 | 500 | 1,830 | 6,500 | 7 K to 6.5 K (-7.14 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.65 | 300 | 1,095 | 7,000 | 7.3 K to 7 K (-4.11 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.62 | 500 | 1,810 | 7,300 | 7.8 K to 7.3 K (-6.41 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.60 | 1,600 | 5,760 | 7,800 | 9.4 K to 7.8 K (-17.02 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.58 | 200 | 716 | 9,400 | 9.6 K to 9.4 K (-2.08 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.57 | 600 | 2,142 | 9,600 | 10.2 K to 9.6 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.56 | 600 | 2,136 | 10,200 | 10.8 K to 10.2 K (-5.56 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.55 | 500 | 1,775 | 10,800 | 11.3 K to 10.8 K (-4.42 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.54 | 500 | 1,770 | 11,300 | 11.8 K to 11.3 K (-4.24 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.53 | 1,200 | 4,236 | 11,800 | 13 K to 11.8 K (-9.23 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | M | 2.40 | 13,000 | 31,200 | 13,000 | 0 to 13 K |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 4.06 | 90,000 | 365,400 | 90,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 1.23 | 100,000 | 123,000 | 100,000 |
Page: 1